Alsita EM 25/1000 Tablet 10's
Rs. 159.44
Title
Alsita EM 25/1000 Tablet 10's
Prescription drug
Expiry
:
31-08-2027
About: Alsita EM 25/1000 Tablet 10's is a high-strength triple antidiabetic combination containing empagliflozin, metformin and sitagliptin for adults with type 2 diabetes requiring intensified glycaemic control.
Usage Instructions: Take the tablet with meals as directed by your doctor, usually once daily, and swallow whole with water; do not break or chew the tablet.
Benefits: Helps significantly reduce blood sugar by combining three complementary mechanisms, potentially reducing the risk of long-term diabetic complications when used along with lifestyle modification.
How it Works: Empagliflozin enhances glucose excretion via kidneys, metformin reduces hepatic glucose output and improves insulin sensitivity, and sitagliptin increases incretin hormone activity to improve insulin response and lower glucagon.
Side Effects: Similar to other SGLT2-DPP4-biguanide combinations, including gastrointestinal upset, urinary/genital infections, volume depletion, hypoglycaemia (with other agents) and rare lactic acidosis or pancreatitis.
Safety Advice: Use only under specialist supervision; avoid in severe renal impairment, ketoacidosis or type 1 diabetes; ensure adequate hydration and regular monitoring of kidney function and blood glucose.
Storage: Store below 25°C in a dry place away from light; keep the medicine out of reach of children.
Usage Instructions: Take the tablet with meals as directed by your doctor, usually once daily, and swallow whole with water; do not break or chew the tablet.
Benefits: Helps significantly reduce blood sugar by combining three complementary mechanisms, potentially reducing the risk of long-term diabetic complications when used along with lifestyle modification.
How it Works: Empagliflozin enhances glucose excretion via kidneys, metformin reduces hepatic glucose output and improves insulin sensitivity, and sitagliptin increases incretin hormone activity to improve insulin response and lower glucagon.
Side Effects: Similar to other SGLT2-DPP4-biguanide combinations, including gastrointestinal upset, urinary/genital infections, volume depletion, hypoglycaemia (with other agents) and rare lactic acidosis or pancreatitis.
Safety Advice: Use only under specialist supervision; avoid in severe renal impairment, ketoacidosis or type 1 diabetes; ensure adequate hydration and regular monitoring of kidney function and blood glucose.
Storage: Store below 25°C in a dry place away from light; keep the medicine out of reach of children.
₹159.44
MRP: ₹177.15
Save ₹17.71
(9%)
Inclusive of all taxes
Quantity
Fresh Stock
Guaranteed
Guaranteed
Secure & Hygienic
Packaging
Packaging
Verified & Trusted
Supplements
Supplements
Secure
Payment
Payment
About: Alsita EM 25/1000 Tablet 10's is a high-strength triple antidiabetic combination containing empagliflozin, metformin and sitagliptin for adults with type 2 diabetes requiring intensified glycaemic control.
Usage Instructions: Take the tablet with meals as directed by your doctor, usually once daily, and swallow whole with water; do not break or chew the tablet.
Benefits: Helps significantly reduce blood sugar by combining three complementary mechanisms, potentially reducing the risk of long-term diabetic complications when used along with lifestyle modification.
How it Works: Empagliflozin enhances glucose excretion via kidneys, metformin reduces hepatic glucose output and improves insulin sensitivity, and sitagliptin increases incretin hormone activity to improve insulin response and lower glucagon.
Side Effects: Similar to other SGLT2-DPP4-biguanide combinations, including gastrointestinal upset, urinary/genital infections, volume depletion, hypoglycaemia (with other agents) and rare lactic acidosis or pancreatitis.
Safety Advice: Use only under specialist supervision; avoid in severe renal impairment, ketoacidosis or type 1 diabetes; ensure adequate hydration and regular monitoring of kidney function and blood glucose.
Storage: Store below 25°C in a dry place away from light; keep the medicine out of reach of children.
Usage Instructions: Take the tablet with meals as directed by your doctor, usually once daily, and swallow whole with water; do not break or chew the tablet.
Benefits: Helps significantly reduce blood sugar by combining three complementary mechanisms, potentially reducing the risk of long-term diabetic complications when used along with lifestyle modification.
How it Works: Empagliflozin enhances glucose excretion via kidneys, metformin reduces hepatic glucose output and improves insulin sensitivity, and sitagliptin increases incretin hormone activity to improve insulin response and lower glucagon.
Side Effects: Similar to other SGLT2-DPP4-biguanide combinations, including gastrointestinal upset, urinary/genital infections, volume depletion, hypoglycaemia (with other agents) and rare lactic acidosis or pancreatitis.
Safety Advice: Use only under specialist supervision; avoid in severe renal impairment, ketoacidosis or type 1 diabetes; ensure adequate hydration and regular monitoring of kidney function and blood glucose.
Storage: Store below 25°C in a dry place away from light; keep the medicine out of reach of children.